A Study of the Safety and Tolerability of LPCN 1144 in Subjects Who Completed the LPCN 1144-18-002 Trial

Completed · Phase 2

Conditions studied: NASH - Nonalcoholic Steatohepatitis

In brief

This is an open-label extension to Study LPCN 1144-18-002. The study is aimed at evaluating the safety and tolerability of LPCN 1144 in adult men with NASH.

Key facts

Study ID
NCT04685993
Run by
Lipocine Inc.
People needed
25
Starts
2020-11-11
Expected to finish
2022-03-01
Last updated by the study team
2024-07-17

Who can join

Age: 18 and older, up to 80. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.